These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29110944)

  • 1. Botulinum Toxin A for the Treatment of Photophobia and Dry Eye.
    Diel RJ; Kroeger ZA; Levitt RC; Sarantopoulos C; Sered H; Martinez-Barrizonte J; Galor A
    Ophthalmology; 2018 Jan; 125(1):139-140. PubMed ID: 29110944
    [No Abstract]   [Full Text] [Related]  

  • 2. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections.
    Diel RJ; Hwang J; Kroeger ZA; Levitt RC; Sarantopoulos CD; Sered H; Felix ER; Martinez-Barrizonte J; Galor A
    Br J Ophthalmol; 2019 Aug; 103(8):1024-1029. PubMed ID: 30269099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid botulinum toxin injections for the dry eye.
    Sahlin S; Linderoth R
    Dev Ophthalmol; 2008; 41():187-192. PubMed ID: 18453769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of botulinum toxin in Horner's muscle for the treatment of dry eye.
    Diaz AL; Chaparro TA; Tello A; Coy H; Frederick GA; Parra MM
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Dec; 93(12):617-620. PubMed ID: 30001848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type a and its uses in dry eye disease.
    Victoria AC; Pino A
    Plast Reconstr Surg; 2012 Jul; 130(1):209e-210e. PubMed ID: 22743932
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M; Schiavi C; Taroni L; Sebastiani S; Bernabei F; Roda M; Moscardelli F; Giannaccare G
    Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of eyelid botulinum toxin injection on lacrimal drainage.
    Sahlin S; Chen E; Kaugesaar T; Almqvist H; Kjellberg K; Lennerstrand G
    Am J Ophthalmol; 2000 Apr; 129(4):481-6. PubMed ID: 10764857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye.
    Serna-Ojeda JC; Nava-Castaneda A
    Acta Ophthalmol; 2017 Mar; 95(2):e132-e137. PubMed ID: 27350144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
    Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
    Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmetic indications for botulinum A toxin.
    Foster JA; Wulc AE; Holck DE
    Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO; Yen MT
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations.
    Freund BJ; Schwartz M
    Br J Oral Maxillofac Surg; 2003 Oct; 41(5):351-2. PubMed ID: 14581034
    [No Abstract]   [Full Text] [Related]  

  • 13. Dry eye syndrome due to botulinum toxin type-A injection: guideline for prevention.
    Ozgur OK; Murariu D; Parsa AA; Parsa FD
    Hawaii J Med Public Health; 2012 May; 71(5):120-3. PubMed ID: 22737648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
    Zúñiga C; Díaz S; Piedimonte F; Micheli F
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interarytenoid botulinum toxin A injection for the treatment of vocal process granuloma.
    Hamdan AL; Khalifee E; Jaffal H; Ghanem A
    J Laryngol Otol; 2019 Dec; 133(12):1041-1045. PubMed ID: 31711548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of botulinum toxin injections in myofascial pain. Response to Gobel et al. Pain 2006;125:82-8.
    Reilich P; Schoser BGH
    Pain; 2007 Aug; 130(3):299. PubMed ID: 17532140
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin type a headache treatment and entrapment of the supratrochlear nerve.
    Saers SJ; de Ru JA
    Arch Dermatol; 2010 Nov; 146(11):1310-1; author reply 1311. PubMed ID: 21079079
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurological picture. Focal botulinum toxin injections lead to rapid resolution of myogenic artefact during EEG monitoring.
    Ekstein D; Shih LC; Sheen V
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):637-8. PubMed ID: 20522871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Cumulative Effects of Repeated Botulinum Toxin Type A Injections on Brow Position.
    Hexsel D; Dal'Forno T; Hexsel C; OliveiraCamozzato F
    Dermatol Surg; 2020 Sep; 46(9):1252-1254. PubMed ID: 31517662
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting migraine responsiveness to botulinum toxin type A injections.
    Kim CC; Bogart MM; Wee SA; Burstein R; Arndt KA; Dover JS
    Arch Dermatol; 2010 Feb; 146(2):159-63. PubMed ID: 20157026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.